Literature DB >> 1871961

Histology and virus expression in the liver: a prognostic puzzle in chronic hepatitis B.

M Rugge1, M Guido, F Bortolotti, M Cassaro, P Cadrobbi, F Noventa, G Realdi.   

Abstract

Forty chronic untreated paediatric carriers of hepatitis B virus (HBV) infection, with no other causes of liver disease, were biopsied on presentation, when the disease was in the active viral replication phase. After a period ranging from 1 to 13 years, all patients underwent a control biopsy. At the time of the last biopsy, 31 of the patients were anti-HBe positive, whereas 9 persisted in the active replication phase. In this latter phase, necrotic and inflammatory lesions and the presence of nuclear HBcAg were found significantly more frequently than when replication had terminated. The necrotic and inflammatory lesions detected in the first biopsy of patients who subsequently underwent anti-HBe seroconversion were significantly more severe than in patients failing to reach seroconversion. All patients who maintained viral replication showed generalized nuclear reactivity for HBcAg on presentation; such reactivity was also found in 16 of 31 (52%) patients who reached anti-HBeAg seroconversion. All these cases had piecemeal necrosis (PMN) in the biopsy. PMN may therefore be considered as a positive prognostic factor in that it identifies those patients who may seroconvert with significant remission of liver disease.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1871961     DOI: 10.1007/bf01600222

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  24 in total

1.  Problems in the management of chronic hepatitis B with interferon: experience in a randomized, multicentre study.

Authors:  G Realdi; G Fattovich; G Pastore; F Caredda; F Noventa; T Santantonio; M Moroni; D Criscuolo; D Maladorno; M Rugge
Journal:  J Hepatol       Date:  1990       Impact factor: 25.083

2.  Serum markers of hepatitis B virus replication, liver histology and intrahepatic expression of hepatitis B core antigen.

Authors:  F Ramalho; M R Brunetto; G Rocca; G G Piccari; A Batista; E Chiaberge; C Lavarini; R P Dal Monte; M Carneiro de Moura; F Bonino
Journal:  J Hepatol       Date:  1988-08       Impact factor: 25.083

3.  The diagnostic value of immunohistochemical demonstration of hepatitis viral antigens in the liver.

Authors:  M A Gerber; S N Thung
Journal:  Hum Pathol       Date:  1987-08       Impact factor: 3.466

4.  The initial morphologic lesion in chronic hepatitis, important or unimportant?

Authors:  B Combes
Journal:  Hepatology       Date:  1986 May-Jun       Impact factor: 17.425

5.  Pattern of core and surface expression in liver tissue reflects state of specific immune response in hepatitis B.

Authors:  F Gudat; L Bianchi; W Sonnabend; G Thiel; W Aenishaenslin; G A Stalder
Journal:  Lab Invest       Date:  1975-01       Impact factor: 5.662

6.  Diverse virological, histopathological and prognostic implications of seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection.

Authors:  I J Su; M Y Lai; H C Hsu; D S Chen; P M Yang; S M Chuang; J L Sung
Journal:  J Hepatol       Date:  1986       Impact factor: 25.083

7.  Correlation between liver histology and markers of hepatitis B virus replication in infected patients: a study by in situ hybridization.

Authors:  C J Burrell; E J Gowans; R Rowland; P Hall; A R Jilbert; B P Marmion
Journal:  Hepatology       Date:  1984 Jan-Feb       Impact factor: 17.425

8.  Prognosis of chronic hepatitis B transmitted from HBsAg positive mothers.

Authors:  F Bortolotti; P Cadrobbi; M Armigliato; L Rude; M Rugge; G Realdi
Journal:  Arch Dis Child       Date:  1987-02       Impact factor: 3.791

9.  Prognostic significance of piecemeal necrosis in acute viral hepatitis.

Authors:  M J Vanstapel; W van Steenbergen; C de Wolf-Peeters; J Desmyter; J Fevery; J de Groote; V J Desmet
Journal:  Liver       Date:  1983-02

10.  Chronic hepatitis in childhood: the spectrum of the disease.

Authors:  F Bortolotti; R Calzia; A Vegnente; P Cadrobbi; M Rugge; M Armigliato; M G Marazzi; R Iorio; C Crivellaro; R Piscopo
Journal:  Gut       Date:  1988-05       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.